SpringWorks Enters into an Exclusive WW License Agreement with Academic Institutions to Advance Portfolio of Mutation-Selective EGFR Inhibitors
Shots: Dana-Farber to receive up front & will be eligible to receive development and commercial milestones along with royalties on product sales SpringWorks has also […]